Urs Regenass

A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and <i>In vitro</i> anti‐proliferative as well as <i>In vivo</i> anti‐tumor activity

Thomas Meyer, Urs Regenass, Doriano Fabbro et al. · International Journal of Cancer · 1989 · 408 citations

Medicine, Medicinal Chemistry, Pharmacology +13

RETRACTED: Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.

Elisabeth Buchdunger, J. Zimmermann, Helmut Mett et al. · Proceedings of the National Academy of Sciences · 1995 · 269 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +14

CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.

Urs Regenass, Helmut Mett, J. Staněk et al. · PubMed · 1994 · 113 citations

Medicine, Oncology, Pharmacology +10

4,5-Dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity.

Elisabeth Buchdunger, Uwe Trinks, Helmut Mett et al. · Proceedings of the National Academy of Sciences · 1994 · 99 citations

Medicine, Oncology, Pharmacology +16

Thiazolidine-diones. Biochemical and biological activity of a novel class of tyrosine protein kinase inhibitors.

Johanna Geissler, Peter Traxler, Urs Regenass et al. · Journal of Biological Chemistry · 1990 · 93 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +15